Advanced Proteome Therapeutics Provides Update on Projects
mcleanap2021-09-09T13:01:11-04:00Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), reports that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), has provided the following update on projects in progress.